Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 9 of 123)
- Relevance
  Sort by

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region

 Report
October 2023
145 Pages
Global

From

€2867EUR$3,150USD£2,458GBP

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027

 Report
November 2022
119 Pages
Global

From

€3595EUR$3,950USD£3,082GBP

US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028

 Report
February 2022
360 Pages
United States

From

€3276EUR$3,600USD£2,809GBP

Non-Small Cell Lung Cancer Market by Type, Treatment Type, Distribution Channel, and Geography: Forecast up to 2027

 Report
July 2023
223 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

HPV Associated Disorders Market by Indication, Therapy, Distribution - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pediatric Drugs and Vaccines - Global Strategic Business Report

 Report
April 2025
292 Pages
Global

From

€5324EUR$5,850USD£4,564GBP

Antibacterial Drugs - Global Strategic Business Report

 Report
April 2025
244 Pages
Global

From

€5324EUR$5,850USD£4,564GBP

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
382 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025

 Report
April 2025
450 Pages
Global

From

€3636EUR$3,995USD£3,117GBP

Collaboration Deals in Pharmaceuticals 2019-2025

 Report
April 2025
950 Pages
Global

From

€3636EUR$3,995USD£3,117GBP

Kidney Cancer Therapeutics and Diagnostics Market Report by Component, Cancer Types, Application, and Region 2025-2033

 Report
January 2025
125 Pages
Global

From

€2729EUR$2,999USD£2,340GBP

Lupus Nephritis Treatment Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4522EUR$4,969USD£3,877GBP

Kidney Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Kidney Cancer Diagnostics and Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Epidural Abscess Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Lung Cancer Drugs Market by Disease, Molecule, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
184 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

Lung Cancer Therapeutics Market by Molecules, Disease, Cancer Type, Therapy, Distribution - Global Forecast 2025-2030

 Report
October 2024
193 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

Non-small Cell Lung Cancer Therapeutics Market by Cancer Type, Drug Class, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

Extensive Stage Small Cell Lung Cancer Market by Treatment Modalities, Drug Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
187 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

Immune Checkpoint Inhibitors for Lung Cancer Market by Products, Type, End-Users - Global Forecast 2025-2030

 Report
October 2024
183 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

2,452 Results (Page 9 of 123)
- 1
- 7
- 8
- 9
- 10
- 11

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.